Bevacizumab for pediatric radiation necrosis.

Lorena V BaroniDaniel AlderetePalma Solano-PaezCarlos RugiloCandela FreytesSuzanne LaughlinAdriana FonsecaUte BartelsUri TaboriEric BouffetAnnie HuangNormand LaperriereDerek S TsangDavid SumerauerMartin KynclBarbora OndrováVajiranee S MalalasekeraJordan R HansfordMichal ZápotockýVijay Ramsawami

Published in: Neuro-oncology practice (2020)

Bevacizumab appears to be effective and well-tolerated in children as treatment for symptomatic radiation necrosis and warrants more robust study in the context of controlled clinical trials.

Keyphrases

clinical trial
metastatic colorectal cancer
young adults
radiation induced
radiation therapy
combination therapy
open label
childhood cancer